Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,078 shares at $12.15 ($14K) on 2023-03-23, disclosed to the SEC on 2023-03-23.
Open-market sale of $14k TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.89 | 349 | $4K | 33.2% |
| 2 | $12.64 | 357 | $5K | 33.3% |
| 3 | $12.15 | 372 | $5K | 33.4% |
| Total | $12.55 avg | 1,078 | $14K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |